The presenting symptoms are fever, cough, and shortness of breath with potential progression to acute respiratory distress syndrome (ARDS) within 2 to 8 days. 4 , 5 Spread occurs primarily through droplets and respiratory secretions (coughs and sneezes) placing otolaryngologists at high risk because of contact with the upper respiratory tract. The first documented global fatality of a physician was that of an otolaryngologist in Wuhan on 25 January 2020. 6 The median incubation period of the virus is estimated to be 5.1 days with 97.5% of those who develop symptoms doing so within 11.5 days. 7 Thus, there exists a time period during which patients are active viral shedders or “silent sentinels” before they become symptomatic, keeping in mind that some exhibit no symptoms. 8 The aim of this contemporary review was to identify opportunities to prevent transmission of the virus and to protect both patients and otolaryngologists, through interpretation of the literature viewed in the light of our daily practice.

In December 2019, a mysterious and rapidly growing cluster of respiratory illnesses originating in the Huanan Seafood Wholesale Market devastated the Wuhan, Hubei Province of China. 1 , 2 It was not until 3 January 2020 that the illness, named the 2019 novel coronavirus (2019‐nCoV or COVID‐19) was identified in samples of bronchoalveolar lavage fluid from a patient in Wuhan and was confirmed as the cause of the pneumonia. 3 Genome analysis indicated that 2019‐nCoVis is a distinct subset of betacoronaviruses associated with human severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome. 3 The 2019‐nCoV has close similarity to bat coronaviruses, and it has been suggested that bats were the primary source. 4

Global medical literature databases and communications were queried to find all available literature recommendations, research, and guidelines applicable otolaryngologists in the COVID‐19 pandemic. Ovid MEDLINE, PubMed, and COCHRANE databases were searched for all available years first for the terms “COVID‐19” or “2019‐nCoV.” Results including the terms “intubation” or “tracheostomy/tracheotomy” or “otolaryngology” or “airway” were then extracted. Articles for which full abstracts or papers were not retrievable or translatable were excluded. Additionally, internet Google and Bing search engine results for “COVID‐19” and “otolaryngology” or “ear, nose and throat” were included. Results that were not relevant to otolaryngologists were excluded. All relevant search results were translated using translation software (whenever necessary) and sources cross‐referenced.

Initial review included 1202 abstracts. Seven articles including case reports and case series met inclusion criteria and were included in the qualitative analysis. Search engine and cross‐referencing results yielded an additional 22 resources. Eight articles were obtained from colleagues in their revision stages. Thirty‐seven sources were deemed to contain relevant information for this compilation.

4 DISCUSSION

4.1 Personal protective equipment As there is no current vaccine for 2019‐nCoV, the Centers for Disease Control and many other entities recommend that the best way to prevent infection is to avoid exposure.9 However, avoiding exposure may not be possible or even an option. In one of the first case series documenting clinical course and a high mortality rate (15%), Huang and colleagues state “airborne precautions, such as a fit‐tested N95 respirator, and other personal protective equipment (PPE) are strongly recommended. To prevent further spread of the disease in health‐care settings that are caring for patients infected with 2019‐nCoV.”5 Like other CoVs, 2019‐nCoV is a positive stranded RNA virus with a spiked‐glycoprotein envelope that is sensitive to ultraviolet rays and heat.10 Furthermore, this virus can be inactivated by lipid solvents including ether (75%), ethanol, chlorine‐containing disinfectant, peroxyacetic acid, and chloroform except for chlorhexidine.11 This is important to note, as many surgical centers provide the option of chlorhexidine scrubs which should not be used if COVID‐19 is a concern. The current CDC recommendations for health care workers treating suspected or confirmed COVID‐19 patients echo those abroad12 recommending (a) nonsterile disposable patient examination gloves, (b) nonsterile, disposable patient isolation gowns, and (c) a surgical N95 (also referred as a medical respirator) for those who need protection from both airborne and fluid hazards (eg, splashes, sprays).13 The use of Powered Air Purifying Respirators (PAPR) masks, especially in the surgical setting, is controversial.14 Given the proximity to nasal‐respiratory secretions, it is prudent for otolaryngologists to wear surgical N95 masks especially if performing any aerosolizing procedures (nasal sprays, nasal and laryngeal endoscopy, etc.). In a safety consensus statement for otolaryngologists, Givi and colleagues propose a risk‐stratified approach to PPE combined with masking (surgical) the patient for high‐risk aerosol‐generating procedures.15 At the time of drafting this document, N95 masks were scarce, prompting the CDC to advocate re‐use of unsoiled masks and the “use homemade masks (eg, bandana, scarf) for care of patients with COVID‐19 as a last resort.”16 Additionally, specific protocol must be followed in removing personal protective equipment to prevent contamination in the process.

4.2 Office/routine clinical visits In the first directed guide for otolaryngologists during the COVID‐19 pandemic, Kai and colleagues in China share that “in view of the high‐risk exposure of the ear, nose, throat and neck surgical staff, the non‐acute and non‐critical routine outpatient and ward work should be reduced as far as possible to cooperate with the national epidemic prevention and control.”17 The rationale stems from the thought that head and neck examination can evoke coughing, pharyngeal reflexes (gagging), and sneezing thereby producing droplets that can carry the virus splashed to a distance of 1 to 2 m, and make the virus aerosolized. The authors go further to state that certain procedures are at risk of spraying, such as nasal sprays/lavage, nosebleed control, and emergency tracheotomy. Accordingly, they recommend tertiary or droplet protection if those procedures are performed. The American Academy of Otolaryngology–Head and Neck Surgery (AAO‐HNS) recommends that “during in‐office examinations, topical medications are more safely applied using pledgets rather than by spray.”18 In an international consensus statement for safety recommendations for head and neck surgery, Givi and colleagues suggest “postponing patients with benign disease (benign salivary or thyroid tumors or patients with hyperparathyroidism), or patients undergoing routine surveillance visits after treatment for head and neck cancer.”13 Although there may be a benefit to delay treatment for less aggressive head and neck cancers, it is recommended that the risks of COVID‐19 transmission be carefully weighed against the risk of cancer progression and survival outcomes for advanced‐stage or aggressive cancers.19 Pre‐screening procedures become mainstay, with pre‐visit questionnaires inquiring about recent travel, fever, cough, or shortness of breath, with patients answering positively directed to COVID‐19 testing sites or self‐quarantine and symptom monitoring.6 A unique symptom that may present to the otolaryngologist is anosmia. Evidences from South Korea (30% as major presenting symptom), Italy, China, Iran, France, and Germany (60% in 2019‐nCoV+ patients) have all reported anosmia.20 If exposure to a COVID‐19 positive patient is known after an encounter, the CDC recommends a “conservative approach to…monitoring and restriction from work (14 days after last exposure)” with high and medium risk exposures (stratified based on PPE present on the provider and facemask on the patient).9 If signs and symptoms develop, otolaryngologists should immediately report to their health facility as well as state and local health authorities who will direct further consultation and testing.

4.3 Surgical cases Echoing the recommendations of Centers for Medicare and Medicaid Services and the American College of Surgeons, the AAO‐HNS released a statement on 19 March 2020, recommending “limiting all non‐essential planned surgeries and procedures, including dental, until further notice.”14 Cases were to be performed based on a tiered surgical framework created by Sameer Siddiqui MD, FACS, at St Louis University which stratifies procedures based on acuity, with only high acuity cases being performed.21 Regarding pediatric otolaryngologic surgical cases, Parikh and colleagues suggest that cases are deemed “urgent if postponement of surgery could negatively impact a child's overall health or developmental outcomes, and a delay of 6 weeks could result in those outcomes being measurably worse.”22 The AAO‐HNS statement also acknowledged the evolving evidence that otolaryngologists are among the highest risk group when performing upper airway surgeries and examinations, stating a high rate of transmission of COVID‐19 to otolaryngologists has been reported from China, Italy, and Iran, many resulting in death. It is believed that viral density is greatest in the nose and nasopharynx and instrumentation in and through these areas would expectedly lead to increased risk. Otologic procedures which require drilling, aerosolize virus particles in an enclosed space, making mastoidectomy procedures as high‐risk as sinonasal procedures.13, 23 As such Saadi and colleagues recommend the use of PAPR if high‐speed drills are required as well as preoperative testing 48 hours prior to surgery, strict quarantine pending test results, and repeat testing on the day of otologic surgery.24 Although the AAO‐HNS's recommendations do not address procedures such as flexible laryngoscopy with or without stroboscopy and nasal endoscopy specifically, they can be reasonably extended to require “extreme caution” when proceeding through a transnasal or trans‐oral route. Surgical procedures should be performed only after ascertaining the COVID‐19 status and if positive performed only with PAPR. Front of neck procedures such as thyroidectomy and neck dissection procedures are considered low risk only if they do not violate the mucosa with added caution to the use of electrocautery which can aerosolize virus present in the bloodstream.13, 15 Notably, facial trauma such as “lacerations that involve mucosal surfaces should be treated as high risk.”14

4.4 General airway management As COVID‐19 has spread from the epicenter in China, several global colleagues developed airway consensus statements and guidelines to address the rate‐limiting factor in transmission: respiratory droplet spread. Droplets are affected by gravity and may cause direct transmission from close contact or contribute to surface contamination (where the virus may remain active for hours to days).25 As many airway management procedures can generate aerosols composed of smaller virus containing particles suspended in air such as coughing, sneezing, positive pressure ventilation, high flow nasal oxygen including OptiFlow devices, nebulization of medications, cardiopulmonary resuscitation, tracheal suction, and tracheal extubation.26 Specific procedures cited as high vulnerability to aerosolization include laryngoscopy, intubation, bronchoscopy, gastroscopy, tracheotomy, and cricothyroidotomy.18 In a consensus statement for airway management during the COVID‐19 pandemic, Brewster, as well as colleagues in China, Boston, and Oregon, stress the importance of early intubation by the most experienced professional (avoid trainees) with a video laryngoscope with only the necessary team members in the room using full droplet PPE.27, 28 They recommend a minimum of 5 minutes pre‐oxygenation with a “(V‐E) grip to maximize the facemask” seal while avoiding a high flow. A critical component of the airway circuit is the presence of a viral filter between the facemask/endotracheal tube and remainder of circuit. It is also recommended that manual ventilation is minimized unless required for rescue. Rapid sequence intubation was the recommended29 and default technique, achieving neuromuscular blockade with rocuronium (>1.5 mg/kg IBW) or suxamethonium (1.5 mg/kg TBW).18 Looking with a fiberoptic flex scope prior to intubation is not recommended. It does not change management in a suspected COVID‐19 patient and risks avoidable exposure to aerosolization. If an irreversible obstruction to the airway is present (stenosis, laryngeal tumor, etc.) that prevents intubation, then tracheotomy should proceed according to COVID‐19 status.30 Avoidance of laryngeal de‐bulking or airway manipulation is recommended by both the United Kingdom and South African Otolaryngology associations.22, 31 Additionally, Brewster and colleagues suggest that minimizing cuff leaks (this might mean accepting higher‐than‐normal cuff pressures or using a larger tube than we would normally suggest) to prevent aerosolization. There is also universal agreement that extubation must proceed with the same precautions as intubation.